Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial - The Lancet Oncology
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020 - IOS Press
Clinical trial design: Past, present, and future in the context of big data and precision medicine - Li - 2020 - Cancer - Wiley Online Library
On Biostatistics and Clinical Trials: Phase I Dose Escalation Study Design: "3 + 3 Design"
Attachment
Moving Beyond 3+3: The Future of Clinical Trial Design | American Society of Clinical Oncology Educational Book
DME Trials - Opthea | Phase 1b & Phase 2a Clinical Trials
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial - The Lancet Oncology
Vaccines | Free Full-Text | Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2 | HTML
The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review - Clinical Therapeutics
Phase 1 clinical trial
Phases of Cancer Clinical Trials - NCI
Colorado COVID Vaccine Guide: How To Find Info Relevant To You | Colorado Public Radio
AN OVERVIEW ON CLINICAL TRIALS
Clinical Trial Phases 1, 2, 3 & 4: Find FDA Clinical Trial Phases.
Immune checkpoint inhibitor-based combinations: is dose escalation mandatory for phase I trials? - Annals of Oncology
Phases of clinical research - Wikipedia
Phases of clinical trials | NCIRS
An overview of precision oncology basket and umbrella trials for clinicians - Park - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis - Gastroenterology
Phase 0/microdosing approaches: time for mainstream application in drug development? | Nature Reviews Drug Discovery
Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity - ScienceDirect
A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer - Gynecologic Oncology
Scheme of the phase 1b clinical trial to assess the efficacy of a... | Download Scientific Diagram
Final Analysis of Results from the Phase Ib/II Trial of Romidepsin and CHOP in Previously Untreated PTCL | Research To Practice
